Toward a new prostate cancer grading system — step 1

In the most recent issue of AUA News, Dr. Jonathon Epstein of  Johns Hopkins — unarguably one of the world’s leading prostate cancer pathologists — has laid out the general principles behind a new, validated, prostate cancer grading system that is designed and intended to replace the traditional Gleason grading system over the next few years. … READ MORE …

The development of drug-resistant, neuroendocrine forms of mCRPC

A sophisticated presentation at the annual meeting of the American Society of Clinical Oncology today (on behalf of the West Coast Prostate Cancer “Dream Team”) gave us insights into the the development of neuroendocrine forms of drug-resistant prostate cancer. … READ MORE …